eRegister's captcha

Patent Register Details

Print page icon Print this page

PATENT REGISTER
A Supplementary Protection Certificate (SPC) exists for this Patent. To view the SPC Details click following SPC number(s): 2019/007
Status Granted Patent No. 2649086
Application No. 11846757.0 Date of Filing 09/12/2011
Date Grant Published 19/07/2017 Application Published 16/10/2013
Title of Invention USE OF CHIMERIC ANTIGEN RECEPTOR-MODIFIED T CELLS TO TREAT CANCER
Priority
Priority Country Filing Date Application No.
 United States of America  09/12/2010  421470 P
 United States of America  29/06/2011  201161502649 P
Inventors JUNE, Carl, H.
LEVINE, Bruce, L.
PORTER, David, L.
KALOS, Michael, D.
MILONE, Michael C.
Current Proprietor The Trustees of The University of Pennsylvania
Center for Technology Transfer 3160 Chestnut Street, Suite 200
Philadelphia PA 19104-6283
UNITED STATES OF AMERICA
Address for service Kilburn & Strode LLP
Lacon London
84 Theobalds Rd
London WC1X 8NL
UNITED KINGDOM
Renewal Fees
Year Date Renewed
 13  23/11/2023
 12  09/12/2022
 11  09/12/2021
 10  09/12/2020
 9  09/12/2019
 8  10/12/2018
 7  11/12/2017
Publication Language English
Translation Received Date
20/07/2017 Divisional Application number: 16199372.0 Date of receipt: 17/11/2016
20/07/2017 Divisional Application number: 17153799.6 Date of receipt: 30/01/2017
12/01/2018 Address for Service recorded as Kilburn & Strode LLP, Lacon London, 84 Theobalds Rd, London WC1X 8NL, United Kingdom received on 04/01/2018.
22/02/2019 Request for grant a Supplementary Protection Certificate, citing Patent number 2649086 as the relevant basic patent, in respect of the product Tisagenlecleucel filed on 15/02/2019. Reference number of request is 2019/007.
15/01/2020 Supplementary Protection Certificate Number 2019/007, having an expiry date of 26/08/2033 granted on 15/01/2020.